This is part of the measures aimed at curbing the spread of the deadly coronavirus disease, just as he said that another batch of 60 million doses is expected to be delivered in 2022.
According to a press statement by his press secretary, Olayinka Oyebode, this disclosure was made by Fayemi, while delivering a paper titled, ‘The role of Nigeria’s State Governments in Recovery: Responses to Covid-19 linked Challenges,” at the Chatham House, Africa Programme, moderated by Elizabeth Donnelly, Deputy Director and Research Fellow at Chatham House.
READ: COVID-19: FG to acquire vaccines that need less cooling
While delivering the paper at the virtual conference held via Zoom, the Governor was quoted as saying that the quantity of the vaccines being expected was released by the National Primary Health Care Development Agency (NPHCDA), at the meeting of the National Economic Council (NEC) last week.
Fayemi said that beyond the government’s efforts at the procurement of vaccines, the NGF had been a strong advocate of the use of public-private partnerships in the procurement of vaccines as a measure of closing the gap between what is available and what is necessary, to achieve herd immunity.
READ: Ministry of Health approves COVID-19 protocols for aviation sector, as airports prepare to resume
What Governor Kayode Fayemi is saying
Fayemi said that the country had conducted about 1.3 million tests so far, out of which 131,242 persons, or 10% of the samples, tested positive to the virus with a case fatality rate of 1.2%.
He said: “As of today, Nigeria has tested 1.3m persons for COVID-19, with 10% (131,242) of these confirmed positive. Compared with the global and Africa’s Case Fatality Rate (CFR) of 2.2% and 2.5% respectively, Nigeria has fared better with a CFR of 1.2%.
READ: Bill Gates identifies one major challenge facing Nigerian economy
“Six States, Lagos, FCT, Plateau, Kaduna, Oyo, and Rivers, have contributed 70% of confirmed cases, with Lagos, the commercial nerve of the country, contributing about 40% of the total burden. Data indicates that men appear to be disproportionately affected, accounting for 69% of the confirmed cases. Most cases occur in people aged 31-40 years.”
On the efforts of government at mitigating the effect of the pandemic on public health and the economy, the governor explained that the private sector, through the Coalition Against COVID-19 (CACOVID), had collaborated with the State and Federal governments in raising more than $75 million to provide medical supplies, equipment, isolation and treatment Centres, as well as food for the vulnerable in the society.
This, he said, was in addition to the expansion of laboratory services across the 36 states and the Federal Capital Territory (FCT) and training of no fewer than 45,000 health workers across the country on infection, prevention and control measures.
READ: NCDC launches online course on COVID-19 and other infectious diseases
The Governor said, “When Nigeria reported its first case in late February 2020, there were only four laboratories in the country that could test for COVID-19. By October 2020, testing capacity had expanded to over 70 laboratories, across the 36 States and the FCT.
“The scale-up of laboratory services was important, given the size of the country and the need to rapidly obtain results for suspected cases. As of December 2020, more than 45,000 health workers have been trained across the country, on infection prevention and control measures,” he said.
What you should know
- It can be recalled that the Minister for Health, Dr. Osagie Ehanire, had at the national briefing of the Presidential Task Force (PTF) on Covid-19, revealed that Nigeria was expected to receive the first batch of COVID-19 vaccines (15 million) from AstraZeneca under the COVAX programme.
- Also, the Executive Director of the National Primary Health Care Development Agency (NPHCDA), Faisal Shuaib, said the Nigerian government expected over 41 million vaccines from the African Union before the end of April, as it also expected to source vaccines from India and Russia.
- He said the vaccines were expected from Pfizer-BioNTech, AstraZeneca, and Johnson & Johnson.